New project to improve understanding of gene regulation landscape
EMBL-EBI and leading UK universities will use zebrafish to study interaction and coordination between gene enhancers in the genome
2025
announcements
New tool offers single-cell study of specific genetic variants
EMBL scientists have developed a more sensitive single-cell sequencing tool that links genomic variants and RNA in the same cell, helping to better uncover links to complex diseases.
SCIENCE & TECHNOLOGY2025
science-technology
Speaking the language of DNA
Right from the early days of DNA sequencing, EMBL’s scientists have been instrumental in helping the world understand, decode, archive, and manipulate genomes at scale and across many branches of the evolutionary tree, a task they continue to excel at today.
SCIENCE & TECHNOLOGY2024
science-technology
Tackling the collateral damage from antibiotics
Researchers from EMBL’s Typas group and collaborators have analysed the effects of 144 antibiotics on the wellbeing of gut microbes. The study improves our understanding of antibiotics’ side effects and suggests a new approach to mitigating the adverse effects of antibiotics therapy on gut…
SCIENCE & TECHNOLOGY2021
sciencescience-technology
Common medications accumulate in gut bacteria
A new collaborative study led by EMBL group leaders Kiran Patil, Nassos Typas, and Peer Bork has found that common medications accumulate in human gut bacteria. This process reduces drug effectiveness and affects the metabolism of common gut microbes, thereby altering the gut microbiome.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
New insights into Salmonella’s survival strategies
Research in the Typas group uncovers new details of the strategies Salmonella uses to survive in infected cells.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
Welcome: Sinem Saka
As one of EMBL’s newest group leaders, Sinem Saka will combine multiple technologies, such as microscopy and single-cell omics, to solve biological puzzles.
LAB MATTERSPEOPLE & PERSPECTIVES2021
lab-matterspeople-perspectives
Finding coronavirus’s helper proteins
A team of EMBL scientists and colleagues have analysed how the novel coronavirus affects proteins in human cells. They identified several human proteins as potential drug targets to prevent viral replication.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
Raising the alarm when DNA goes bad
Our genome is constantly under attack from things like UV light and toxins, which can damage or even break DNA strands and ultimately lead to cancer and other diseases. Scientists have known for a long time that when DNA is damaged, a key enzyme sets off a cellular ‘alarm bell’ to alert the…
SCIENCE & TECHNOLOGY2009
sciencescience-technology
Sugarcoating fruit fly development
Proteins are the executive agents that carry out all processes in a cell. Their activity is controlled and modified with the help of small chemical tags that can be dynamically added to and removed from the protein. 25 years after its first discovery, researchers at the European Molecular Biology…
SCIENCE & TECHNOLOGY2009
sciencescience-technology
No results found